Virax Biolabs Group Limited

Q2 2024 13F Holders

Symbol
VRAX
CUSIP
G9495L125
Type
Equity
Class
SHS NEW
Num filings
8
Total reported value, excl. options
$81.8 k
Manager Report Date Value ($000) Shares Option Type